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Case Report
A 37-year-old female known for systemic lupus erythematosus
underwent a right thyroid lobectomy for a growing nodule in
the right lobe. A fine-needle aspiration biopsy (FNAB)
performed 4 years before surgery reported a microfollicular
proliferation. A second FNAB performed a few months before
surgery revealed a benign lesion. The surgical specimen was
fixed in 4 % buffered formaldehyde. The entire nodule was
sampled, with particular attention to the capsule, and embedded
in paraffin and corresponding sections were stained with
hematoxylin and eosin for histological examination. Immuno-
histochemistry using HBME1 and galectin-3 was performed.
What is Your Diagnosis?
The pathological diagnosis of the patient was follicular
thyroid carcinoma, macrofollicular variant, which is minimally
invasive, stage pT2 pNX.
On gross section, the nodule measured 4×4×3.5 cm. It
was encapsulated with a shiny colloidal appearance without
calcification (Fig. 1a). On histology, the nodule was encap-
sulated, with variable capsule thickness. It was essentially
macrofollicular (>200 μm) with a minor microfollicular
component (Fig. 1b). The cells were attenuated to cuboidal
with an eosinophilic cytoplasm and round hyperchromatic
nuclei without any nuclear feature suspicious for papillary
thyroid carcinoma (PTC) (Fig. 1c). No mitotic activity or
necrosis was found. Focal transcapsular invasion was
present (Fig. 1b), but no vascular invasion was found.
Immunohistochemistry showed focal but strong HBME-1
staining essentially in the microfollicular areas (Fig. 1d)
and absence of galectin-3 staining.
Comment
Here, we report the case of a minimally invasive follicular
thyroid carcinoma (FTC) with a predominant macrofollicular
growth pattern. Thyroid nodules with a macrofollicular
architecture are considered for the most part as benign
lesions and include nodular hyperplasia, adenomatous
nodules, and some follicular adenomas. In contrast,
FTCs are generally hypercellular and very few exhibit
normofollicular or macrofollicular appearances [1]. There-
fore, the index of suspicion should be raised whenever
encountering a follicular neoplasm with a solid, trabecular, or
microfollicular pattern of growth [1]. However, rare cases
of thyroid malignant neoplasms with a macrofollicular
pattern have been described such as the macrofollicular
variant of PTC [2] and the even rarer macrofollicular
variant of FTC [3]. Thus, lesions with a predominant
macrofollicular component should also be assessed for nuclear
features of PTC and for capsule and vascular invasion.
Therefore, sampling the entire capsule is recommended.
Correspondingly, FNAB provides essential informa-
tion regarding architectural and cytology aspects of the
thyroid nodules and plays a key role as a screening test
for thyroid follicular neoplasms [4, 5]. FTC classically
shows microfollicular growth pattern and identification
of this component is the key feature in order to classify these
nodules as suspicious for a follicular neoplasm, even though
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the majority (>70%) of these nodules turn out to be benign on
surgical follow-up [4, 5]. Thus, cytological specimens of
macrofollicular variant of FTC can be a pitfall and be
misinterpreted as benign due to the lack of microfollicles
[5]. Therefore, they may account for an undetermined fraction
of the false-negative FNAB cases. However, some of these
cases may fall into oblivion and never be detected as their
malignant potential, if any, may never be apparent. Immuno-
histochemistry (e.g., HBME-1, galectin-3) may support the
diagnosis of malignancy for this rare variant of FTC with
deceivably bland architectural and cytological features.
In conclusion, this case report illustrates a rare macro-
follicular variant of FTC that can be misdiagnosed as a
benign lesion, supports the need to thoroughly sample the
nodule capsule, and assesses for vascular and capsular invasion
also in macrofollicular patterned thyroid nodules.
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Fig. 1 a Macroscopical aspect
of the macrofollicular variant of
follicular thyroid carcinoma. b
The tumor is encapsulated and
shows a “mushroom-like” focus
of transcapsular invasion into
the adjacent thyroid
parenchyma. c The tumor is
composed mainly of
macrofollicles lined with
cuboidal or attenuated cells
with bland nuclear features.
d Tumor cells in the minor
microfollicular areas are
strongly immunopositive
for HBME-1
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